June 29, 2011 | Yesterday Eli Lilly announced plans to make a mulitmillion-dollar investment in its biotech business, but declined to give a specific number. The goal is to develop multispecific therapies to focus on chronic diseases like diabetes, cancer, and autoimmune disease. Bloomberg.